CervoMed Inc. — Director's Dealing 2024

Jan 26, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CervoMed Inc. (CRVO)
CIK: 0001053691
Period of Report: 2024-01-26

Reporting Person: TANNER JOHN WILLIAM (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-01-26	Stock Option (Right to Buy)	$9.05	A	16000	Acquired	2034-01-26	Common Stock (16000)	Direct

Footnotes

F1: The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2024.